ExamPat
← Back to reexams

90/020,096METHODS AND COMPOSITIONS FOR TREATING CANCER8,822,438Closed

Status

Incomplete Ex Parte Reexam (Filing Date Vacated)

Filed

Jan 18, 2016

Last Updated

Apr 7, 2016

Art Unit

3991

Requester Law Firm

Unknown

Requested By

Third Party

P.O. Law Firm

David A. Lane, Jr.

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (23 events)

Jun 14, 2016MRXPRRX - Mail Termination of PreProcessing of Ex Parte Rexxamination Request
Apr 12, 2016NRX.Notice of Reexam Published in Official Gazette
Apr 7, 2016MRIFDRX - Mail Incomplete Ex Parte Reexam Request (Filing Date vacated)
Mar 9, 2016MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Mar 7, 2016RXWVSTWaiver of owners statement in ex parte
Mar 2, 2016RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Mar 2, 2016RXNREQFDNotice of reexamination request filing date
Mar 2, 2016RXNREQAUNotice of assignment of reexamination request
Mar 2, 2016RXLITSRReexam Litigation Search Conducted
Mar 2, 2016FTFIFITF set to NO - revise initial setting
Mar 2, 2016DOCKCase Docketed to Examiner in GAU
Feb 17, 2016WIDSInformation Disclosure Statement (IDS) Filed
Feb 17, 2016RXOSUCOrig Req Receipt Corrected
Feb 17, 2016RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Feb 17, 2016RXC/SRCertificate of Service
Feb 4, 2016MRICRRX - Mail Notice of Incomplete Ex Parte Reexam Request
Feb 3, 2016SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Feb 3, 2016RXTTLRPTTitle Report
Jan 18, 2016WIDSInformation Disclosure Statement (IDS) Filed
Jan 18, 2016RXOSUB.RReexamination requested by third party requester
Jan 18, 2016RXOSUBReceipt of Original Ex Parte Reexam Request
Jan 18, 2016RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Jan 18, 2016BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

IPR2017-00853IPR — Final Written Decision

Petitioner

ACTAVIS LABORATORIES FL, INC. et al.

Petition Filed

Feb 8, 2017

Institution

Apr 12, 2017

Terminated

Jan 17, 2018

IPR2016-01582IPR — Final Written Decision

Petitioner

Wockhardt Bio AG et al.

Petition Filed

Aug 10, 2016

Institution

Jan 19, 2017

Terminated

Jan 17, 2018

IPR2016-01332IPR — Final Written Decision

Petitioner

Mylan Pharmaceuticals Inc. et al.

Petition Filed

Jun 30, 2016

Institution

Jan 10, 2017

Terminated

Jan 17, 2018

IPR2016-01317IPR — Final Written Decision

Petitioner

Argentum Pharmaceuticals LLC et al.

Petition Filed

Jun 29, 2016

Institution

Sep 19, 2016

Terminated

Jan 17, 2018

IPR2016-00286IPR — Final Written Decision

Petitioner

Amerigen Pharmaceuticals, Ltd.

Petition Filed

Dec 4, 2015

Institution

May 31, 2016

Terminated

Jan 17, 2018

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Sep 2, 2014
3.5-yr
Mar 2, 2018
Paid Feb 15, 2018
7.5-yr
Mar 2, 2022
Paid Feb 16, 2022
11.5-yr
Mar 2, 2026
Expiry
Feb 24, 2031

Entity Status

Large Entity

Expires

Feb 24, 2031 (4.9 yr remaining)

Assignments

201220132014201520162017FiledJOHANN S DE BONOINSTITUTE FOR CANCER RESEARCHBRITISH TECHNOLOGY GROUP LIMITEDINSTITUTE OF CANCER RESEARCH
AssignmentReel/Frame: 043280/0228Recorded: Aug 14, 2017

From

INSTITUTE FOR CANCER RESEARCH
Feb 16, 2016
→

To

BRITISH TECHNOLOGY GROUP LIMITED

AssignmentReel/Frame: 043279/0833Recorded: Aug 14, 2017

From

JOHANN S DE BONOInventor
Jun 21, 2017
→

To

INSTITUTE OF CANCER RESEARCH